Drugs / Thymopentin

Trials 9 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT06112041 Oct 2023 → Oct 2026 expected carcinoma Second Affiliated Hospital of Soochow University Not yet recruiting No outcome recorded
Phase 2 NCT00002332 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
Phase 32 trials
Phase 3 NCT00460681 Feb 2007 → Feb 2012 hepatocellular carcinoma Fudan University Unknown No outcome recorded
Phase 3 NCT00002109 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
Phase not applicable5 trials
NCT00002049 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
NCT00002051 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
NCT00002066 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
NCT00002050 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded
NCT00002289 HIV infectious disease Immunobiology Research Institute Completed No outcome recorded

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as Thymopentin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00460681
8

NCT06112041

NCT00002051

NCT00002109

NCT00002289

NCT00002049

NCT00002050

NCT00002332

NCT00002066

Known as Arg-lys-asp-val-tyr ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Hg-thymopentin ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Immunox ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as NSC-760116 ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as ORF 15244 ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Oristar thymopentin ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Pentapeptide-1 ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Sh-pentapeptide-1 ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Sintomodulina ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Thymopentine ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Thymopoetin 32-36-pentapeptide ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Thymopoietin 32-36 ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Thymopoietin pentapeptide ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Timopentina ChEMBL registry synonym — accepted as the source's own label CHEMBL156025
Known as Timunox “Examine the ability of Timunox (thymopentin) to reduce the amount and/or frequency of virus isolation.” NCT00002049
4

“Examine the ability of Timunox (thymopentin) to reduce the amount and/or frequency of virus isolation.” NCT00002289

“Examine the ability of Timunox (thymopentin) to reduce the amount and/or frequency of virus isolation.” NCT00002050

“Examine the ability of thymopentin (Timunox) to:” NCT00002066

“Examine the ability of thymopentin (Timunox) to:” NCT00002051

Known as TP5 “Immunomodulatory peptides, like thymopentin (TP5), may act as immunomodulatory agents in cancer chemotherapy.” NCT00460681
Modality Peptide “Immunomodulatory peptides, like thymopentin (TP5), may act as immunomodulatory agents in cancer chemotherapy.” NCT00460681
Route Subcutaneous “Patients are randomized to receive subcutaneous thymopentin or placebo thrice weekly for 4 weeks.” NCT00002332